Functional activation of lymphocyte CD44 in peripheral blood is a marker of autoimmune disease activity.
Interactions between complementary receptors on leukocytes and endothelial cells play a central role in regulating extravasation from the blood and thereby affect both normal and pathologic inflammatory responses. CD44 on lymphocytes that has been "activated" to bind its principal ligand hyaluronate (HA) on endothelium can mediate the primary adhesion (rolling) of lymphocytes to vascular endothelial cells under conditions of physiologic shear stress, and this interaction is used for activated T cell extravasation into an inflamed site in vivo in mice (DeGrendele, H.C., P. Estess, L.J. Picker, and M.H. Siegelman. 1996. J. Exp. Med. 183:1119-1130. DeGrendele, H.D., P. Estess, and M.H. Siegelman. 1997. Science. 278:672-675. DeGrendele, H.C., P. Estess, and M.H. Siegelman. 1997. J. Immunol. 159: 2549-2553). Here, we have investigated the role of lymphocyte-borne-activated CD44 in the human and show that CD44-dependent primary adhesion is induced in human peripheral blood T cells through T cell receptor triggering. In addition, lymphocytes capable of CD44/HA-dependent rolling interactions can be found resident within inflamed tonsils. In analysis of peripheral bloods of patients from a pediatric rheumatology clinic, examining systemic lupus erythematosus, and a group of chronic arthropathies, expression of CD44-dependent primary adhesion strongly correlates with concurrent symptomatic disease, with 85% of samples from clinically active patients showing elevated levels of rolling activity (compared with only 4% of inactive patients). These rolling interactions are predominantly mediated by T cells. The results suggest that circulating T lymphocytes bearing activated CD44 are elevated under conditions of chronic inflammation and that these may represent a pathogenically important subpopulation of activated circulating cells that may provide a reliable marker for autoimmune or chronic inflammatory disease activity.
Estess
P
P
Laboratory of Molecular Pathology, Department of Pathology, The University of Texas Southwestern Medical Center Dallas, Dallas, TX 75235, USA.
DeGrendele
H C
HC
Pascual
V
V
Siegelman
M H
MH
D000293:Adolescent; D001327:Autoimmune Diseases / Q000175:diagnosis*; D002448:Cell Adhesion; D002634:Chemotaxis, Leukocyte; D002648:Child; D002675:Child, Preschool; D004730:Endothelium, Vascular / Q000276:immunology; D005260:Female; D006801:Humans; D018960:Hyaluronan Receptors / Q000097:blood*; D006820:Hyaluronic Acid / Q000378:metabolism; D007223:Infant; D007592:Joint Diseases / Q000276:immunology; D008180:Lupus Erythematosus, Systemic / Q000276:immunology; D016131:Lymphocyte Subsets / Q000276:immunology*; D008297:Male; D014066:Palatine Tonsil / Q000276:immunology; D011948:Receptors, Antigen, T-Cell / Q000276:immunology; D012216:Rheumatic Diseases / Q000276:immunology
D018960:Hyaluronan Receptors; D011948:Receptors, Antigen, T-Cell; D006820:Hyaluronic Acid